Holen Sie sich die Stockscreener-App
1.63
1.21%
-0.02
Vorhandelsmarkt:
1.58
-0.05
-3.07%
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.82%
10.43
|
14.86 | 12.01 | 5.863 | 28.19 |
| Depreciation and Amortization |
9.38%
0.035
|
0.032 | 0.016 | 0.086 | 0.044 |
| Operating Income/Loss |
29.82%
-10.43
|
-14.86 | -12.01 | -5.863 | -28.19 |
| Income/Loss From Continuing Operations Before Tax |
6.22%
-15.91
|
-14.98 | -12.45 | -5.466 | -27.66 |
| Income Tax Expense/Benefit |
42.55%
0.067
|
0.047 | 0.007 | 0.013 | 0.036 |
| Income/Loss From Continuing Operations After Tax |
6.33%
-15.98
|
-15.03 | -12.46 | -5.479 | -27.69 |
|
Net Income/Loss
|
6.33%
-15.98
|
-15.03 | -12.46 | -5.479 | -27.69 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
0.067
|
- | - | 0.013 | 0.036 |
| Basic Average Shares |
6.25%
46.69
|
43.94 | 0.1716 | 43.16 | 43.10 |
| Diluted Average Shares |
6.25%
46.69
|
43.94 | 0.1716 | 43.16 | 43.10 |
| Basic Earnings Per Share |
0.00%
-0.34
|
-0.34 | -0.28 | -0.13 | -0.64 |
| Diluted Earnings Per Share |
0.00%
-0.34
|
-0.34 | -0.28 | -0.13 | -0.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):